0001214659-21-000827.txt : 20210126 0001214659-21-000827.hdr.sgml : 20210126 20210126174848 ACCESSION NUMBER: 0001214659-21-000827 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210122 FILED AS OF DATE: 20210126 DATE AS OF CHANGE: 20210126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daniels Mark CENTRAL INDEX KEY: 0001753840 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38720 FILM NUMBER: 21555658 MAIL ADDRESS: STREET 1: C/O TWIST BIOSCIENCE CORPORATION STREET 2: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Twist Bioscience Corp CENTRAL INDEX KEY: 0001581280 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462058888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 800-719-0671 MAIL ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-51261.xml PRIMARY DOCUMENT X0306 4 2021-01-22 0001581280 Twist Bioscience Corp TWST 0001753840 Daniels Mark C/O TWIST BIOSCIENCE CORPORATION 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 false true false false See Remarks Common Stock 2021-01-22 4 F false 149 190.64 D 68485 D Common Stock 2021-01-25 4 S false 285 193.00 D 68200 D Common Stock 2021-01-25 4 M false 620 23.33 A 68820 D Common Stock 2021-01-25 4 S false 620 193.00 D 68200 D Employee Stock Option (right to buy) 23.33 2021-01-25 4 M false 620 0 D 2029-10-23 Common Stock 620 20475 D Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. 25% of the shares subject to the option vested and became exercisable on October 24, 2020 , and 1/48th of the shares subject to the option vest and become exerisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Senior Vice President, Chief Legal Officer, Chief Ethics and Compliance Officer, and Secretary /s/ William Solis, as Attorney-in-Fact for Mark Daniels 2021-01-26